Search Results - "CHISHOLM, G. D"

Refine Results
  1. 1

    Results of Conservative Management of Clinically Localized Prostate Cancer by Chodak, Gerald W, Thisted, Ronald A, Gerber, Glenn S, Johansson, Jan-Erik, Adolfsson, Jan, Jones, George W, Chisholm, Geoff D, Moskovitz, Boaz, Livne, Pinhas M, Warner, John

    Published in The New England journal of medicine (27-01-1994)
    “…Prostate cancer is now the most common cancer and the second most common cause of death from cancer among men in the United States 1 . Both the incidence and…”
    Get full text
    Journal Article
  2. 2

    Changes in urinary cytokines and soluble intercellular adhesion molecule‐1 (ICAM‐1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapy by JACKSON, A. M., ALEXANDROFF, A. B., KELLY, R. W., SKIBINSKA, A., ESUVARANATHAN, K., PRESCOTT, S., CHISHOLM, G. D., JAMES, K.

    Published in Clinical and experimental immunology (01-03-1995)
    “…SUMMARY Intravesical immunotherapy for carcinoma in situ of the bladder is arguably the most effective form of tumour immunotherapy described to date…”
    Get full text
    Journal Article
  3. 3

    Experience with the McCoy laryngoscope in difficult laryngoscopy by Chisholm, D. G., Calder, I.

    Published in Anaesthesia (01-09-1997)
    “…We report our experience with the McCoy levering laryngoscope in 48 patients who were a Cormack and Lehane grade 3 or grade 4 view at direct laryngoscopy. The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall by Prescott, S, James, K, Hargreave, T B, Chisholm, G D, Smyth, J F

    Published in The Journal of urology (01-06-1992)
    “…Previous studies have demonstrated that is is the local immune response which is of importance for the anti-tumour activity of BCG therapy. We have…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Interleukin-6 production by bladder tumors is upregulated by BCG immunotherapy by Esuvaranathan, K, Alexandroff, A B, McIntyre, M, Jackson, A M, Prescott, S, Chisholm, G D, James, K

    Published in The Journal of urology (1995)
    “…To determine whether BCG therapy could upregulate interleukin-6 (IL-6) production in human transitional cell carcinomas (TCC). Immunohistochemistry of tumor…”
    Get more information
    Journal Article
  8. 8

    Epidermal growth factor and transforming growth factor α concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels by YANG, Y, CHISHOLM, G. D, HABIB, F. K

    Published in British journal of cancer (01-01-1993)
    “…We measured immunoreactive EGF and TGF alpha in prostate tissue extracts obtained from 19 patients with benign prostatic hyperplasia (BPH) and 19 with cancer…”
    Get full text
    Journal Article
  9. 9

    Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha by Jackson, A M, Alexandrov, A B, Prescott, S, James, K, Chisholm, G D

    Published in The Journal of urology (01-11-1992)
    “…The constitutive expression by eight human bladder cancer cell lines of the cell adhesion molecules intercellular adhesion molecule-1 and intercellular…”
    Get more information
    Journal Article
  10. 10

    Basaloid carcinoma of the prostate gland: histogenesis and review of the literature by Denholm, S W, Webb, J N, Howard, G C, Chisholm, G D

    Published in Histopathology (01-02-1992)
    “…The clinicopathological features of a basaloid carcinoma of the prostate gland are described in a 28-year-old man, and the management and prognosis discussed…”
    Get more information
    Journal Article
  11. 11

    Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour by MADDY, S. Q, CHISHOLM, G. D, BUSUTTIL, A, HABIB, F. K

    Published in British journal of cancer (01-07-1989)
    “…The presence of specific and high affinity epidermal growth factor receptors (EGF-R) has been demonstrated in human prostate cancer (CaP). Scatchard analysis…”
    Get full text
    Journal Article
  12. 12

    Production and response of a human prostatic cancer line to transforming growth factor-like molecules by MACDONALD, A, CHISHOLM, G. D, HABIB, F. K

    Published in British journal of cancer (01-10-1990)
    “…Serum-free media conditioned by the androgen insensitive human prostate cancer cell line DU145 showed immunological transforming growth factor-alpha (TGF…”
    Get full text
    Journal Article
  13. 13

    Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods by Maddy, S Q, Chisholm, G D, Hawkins, R A, Habib, F K

    Published in Journal of endocrinology (01-04-1987)
    “…The receptor for epidermal growth factor (EGF) was characterized in the particulate fraction from human benign prostatic hyperplasia (BPH) and was present in…”
    Get more information
    Journal Article
  14. 14

    Immunocompetent cells in human testis in health and disease by el-Demiry, M I, Hargreave, T B, Busuttil, A, Elton, R, James, K, Chisholm, G D

    Published in Fertility and sterility (01-09-1987)
    “…The authors have investigated lymphocyte subpopulations and macrophages in normal human testes and the testes of patients under investigation and treatment for…”
    Get more information
    Journal Article
  15. 15

    The effect of recombinant cytokines on bladder cancer cells in vitro by Hawkyard, S J, Jackson, A M, Prescott, S, James, K, Chisholm, G D

    Published in The Journal of urology (01-08-1993)
    “…We have studied the Major Histocompatibility Class II-modulating and antiproliferative actions of recombinant interferon-gamma, tumor necrosis factor-alpha,…”
    Get more information
    Journal Article
  16. 16

    The inhibitory effects of interferon gamma on the growth of bladder cancer cells by Hawkyard, S J, Jackson, A M, James, K, Prescott, S, Smyth, J F, Chisholm, G D

    Published in The Journal of urology (01-05-1992)
    “…The inhibitory effect of interferon-gamma on the growth of three human bladder cancer cell lines, RT4, RT112 and MGH-U1, representing tumour grades 1, 2 and 3…”
    Get more information
    Journal Article
  17. 17

    Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia by Habib, Fouad K., Ross, Margaret, Tate, Rothwell, Chisholm, Geoffrey D.

    Published in Clinical endocrinology (Oxford) (01-02-1997)
    “…OBJECTIVE The 5α‐reductase inhibitor, finasteride, provides a logical medical treatment for benign prostatic hyperplasia (BPH). However, the effects of chronic…”
    Get full text
    Journal Article
  18. 18

    Is the outcome of conservative management for localized prostate cancer acceptable? An overview by Chisholm, G D, Rana, A

    Published in European urology (1993)
    “…The outcome of conservative management in a consecutive series of 107 localized prostate cancers (mean age 73.5 years) has been analyzed. Follow-up ranged from…”
    Get more information
    Journal Article
  19. 19

    The natural history of renal carcinoma by Ritchie, A W, Chisholm, G D

    Published in Seminars in oncology (01-12-1983)
    “…In summary, some evidence indicating an increase in incidence of renal parenchymal malignancy has been presented. The nature of renal adenoma and its…”
    Get more information
    Journal Article
  20. 20